Cargando…

Study of efficacy and safety of reconstituted, recombinant human interferon alpha 2b eyedrops without refrigeration as a therapy for immunoreduction and/or treatment of ocular surface squamous neoplasia

Detalles Bibliográficos
Autores principales: Kabra, Namrata S, Patil, Vaibhav S, Dhanuka, Dolly G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8837334/
https://www.ncbi.nlm.nih.gov/pubmed/34827049
http://dx.doi.org/10.4103/ijo.IJO_885_21
_version_ 1784649885707927552
author Kabra, Namrata S
Patil, Vaibhav S
Dhanuka, Dolly G
author_facet Kabra, Namrata S
Patil, Vaibhav S
Dhanuka, Dolly G
author_sort Kabra, Namrata S
collection PubMed
description
format Online
Article
Text
id pubmed-8837334
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-88373342022-03-07 Study of efficacy and safety of reconstituted, recombinant human interferon alpha 2b eyedrops without refrigeration as a therapy for immunoreduction and/or treatment of ocular surface squamous neoplasia Kabra, Namrata S Patil, Vaibhav S Dhanuka, Dolly G Indian J Ophthalmol Letters to the Editor Wolters Kluwer - Medknow 2021-12 /pmc/articles/PMC8837334/ /pubmed/34827049 http://dx.doi.org/10.4103/ijo.IJO_885_21 Text en Copyright: © 2021 Indian Journal of Ophthalmology https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 4.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Letters to the Editor
Kabra, Namrata S
Patil, Vaibhav S
Dhanuka, Dolly G
Study of efficacy and safety of reconstituted, recombinant human interferon alpha 2b eyedrops without refrigeration as a therapy for immunoreduction and/or treatment of ocular surface squamous neoplasia
title Study of efficacy and safety of reconstituted, recombinant human interferon alpha 2b eyedrops without refrigeration as a therapy for immunoreduction and/or treatment of ocular surface squamous neoplasia
title_full Study of efficacy and safety of reconstituted, recombinant human interferon alpha 2b eyedrops without refrigeration as a therapy for immunoreduction and/or treatment of ocular surface squamous neoplasia
title_fullStr Study of efficacy and safety of reconstituted, recombinant human interferon alpha 2b eyedrops without refrigeration as a therapy for immunoreduction and/or treatment of ocular surface squamous neoplasia
title_full_unstemmed Study of efficacy and safety of reconstituted, recombinant human interferon alpha 2b eyedrops without refrigeration as a therapy for immunoreduction and/or treatment of ocular surface squamous neoplasia
title_short Study of efficacy and safety of reconstituted, recombinant human interferon alpha 2b eyedrops without refrigeration as a therapy for immunoreduction and/or treatment of ocular surface squamous neoplasia
title_sort study of efficacy and safety of reconstituted, recombinant human interferon alpha 2b eyedrops without refrigeration as a therapy for immunoreduction and/or treatment of ocular surface squamous neoplasia
topic Letters to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8837334/
https://www.ncbi.nlm.nih.gov/pubmed/34827049
http://dx.doi.org/10.4103/ijo.IJO_885_21
work_keys_str_mv AT kabranamratas studyofefficacyandsafetyofreconstitutedrecombinanthumaninterferonalpha2beyedropswithoutrefrigerationasatherapyforimmunoreductionandortreatmentofocularsurfacesquamousneoplasia
AT patilvaibhavs studyofefficacyandsafetyofreconstitutedrecombinanthumaninterferonalpha2beyedropswithoutrefrigerationasatherapyforimmunoreductionandortreatmentofocularsurfacesquamousneoplasia
AT dhanukadollyg studyofefficacyandsafetyofreconstitutedrecombinanthumaninterferonalpha2beyedropswithoutrefrigerationasatherapyforimmunoreductionandortreatmentofocularsurfacesquamousneoplasia